Key regions: Australia, Italy, France, South Korea, Brazil
The demand for vaccines in El Salvador has been on the rise in recent years, with a growing number of individuals seeking immunization against various diseases.
Customer preferences: The preference for vaccines has been driven by a number of factors, including the increasing awareness of the importance of preventive healthcare, the availability of a wide range of vaccines, and the ease of access to healthcare services. In addition, the government of El Salvador has been actively promoting vaccination programs, which has helped to increase awareness and encourage more individuals to get vaccinated.
Trends in the market: One of the key trends in the vaccines market in El Salvador is the growing demand for vaccines for preventable diseases such as measles, mumps, and rubella. This trend is largely driven by the increasing awareness of the importance of preventive healthcare and the availability of vaccines that can help to prevent these diseases. In addition, there has been a growing demand for vaccines that can help to prevent infectious diseases such as hepatitis A and B, as well as influenza.
Local special circumstances: One of the unique aspects of the vaccines market in El Salvador is the role of the government in promoting vaccination programs. The government has been actively involved in promoting vaccination campaigns and providing access to vaccines, particularly for children. This has helped to increase awareness of the importance of vaccination and encourage more individuals to get vaccinated.
Underlying macroeconomic factors: The growing demand for vaccines in El Salvador is also being driven by a number of underlying macroeconomic factors, including the increasing population, rising disposable income, and improving healthcare infrastructure. As the population continues to grow and become more affluent, the demand for healthcare services, including vaccines, is likely to continue to increase. In addition, the government's efforts to improve healthcare infrastructure and increase access to healthcare services are likely to further drive demand for vaccines in the country.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
